Search research articles
Contact Us
Filters
Showing results (201-210 of 269) with videos related to
Page
of 27
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
May 29, 2021
Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [<sup>18</sup>F]FDG PET/CT and MRI
Christian Linz, Roman C Brands, Olivia Kertels, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 9, 2023
Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [<sup>18</sup>F]FDG
Aleksander Kosmala, Johannes Duell, Simone Schneid, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 20, 2023
[<sup>18</sup>F]FET-PET in children and adolescents with central nervous system tumors: does it support difficult clinical decision-making?
Olivia Kertels, Jürgen Krauß, Camelia Maria Monoranu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 8, 2018
Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on <sup>18</sup>F-DCFPyL PET/CT Imaging
Rudolf A Werner, Ralph A Bundschuh, Lena Bundschuh, et al.
Theranostics
|
August 22, 2017
<sup>11</sup>C-Methionine-PET in Multiple Myeloma: A Combined Study from Two Different Institutions
Constantin Lapa, Maria J Garcia-Velloso, Katharina Lückerath, et al.
Oncotarget
|
October 27, 2016
Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI
Constantin Lapa, Theresa Reiter, Malte Kircher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 29, 2021
<sup>68</sup>Ga-Pentixafor PET/CT for Detection of Chemokine Receptor CXCR4 Expression in Myeloproliferative Neoplasms
Sabrina Kraus, Alexander Dierks, Leo Rasche, et al.
Cancers
|
April 29, 2020
<sup>18</sup>F-FDG and <sup>11</sup>C-Methionine PET/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET Biomarkers
Maria I Morales-Lozano, Oliver Viering, Samuel Samnick, et al.
Frontiers in Oncology
|
June 28, 2019
[<sup>68</sup>Ga]-Pentixafor PET/CT for CXCR4-Mediated Imaging of Vestibular Schwannomas
Maria Breun, Camelia M Monoranu, Almuth F Kessler, et al.
Molecular Imaging and Biology
|
August 1, 2024
Interobserver Agreement Rates on CXCR4-Directed PET/CT in Patients with Marginal Zone Lymphoma
Rudolf A Werner, Yingjun Zhi, Niklas Dreher, et al.
Page
of 27
Search research articles
Search
Showing results (201-210 of 269) with videos related to
Sort By:
Page
of 27
European Journal of Nuclear Medicine and Molecular Imaging
|
May 29, 2021
Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [<sup>18</sup>F]FDG PET/CT and MRI
Christian Linz, Roman C Brands, Olivia Kertels, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 9, 2023
Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [<sup>18</sup>F]FDG
Aleksander Kosmala, Johannes Duell, Simone Schneid, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 20, 2023
[<sup>18</sup>F]FET-PET in children and adolescents with central nervous system tumors: does it support difficult clinical decision-making?
Olivia Kertels, Jürgen Krauß, Camelia Maria Monoranu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 8, 2018
Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on <sup>18</sup>F-DCFPyL PET/CT Imaging
Rudolf A Werner, Ralph A Bundschuh, Lena Bundschuh, et al.
Theranostics
|
August 22, 2017
<sup>11</sup>C-Methionine-PET in Multiple Myeloma: A Combined Study from Two Different Institutions
Constantin Lapa, Maria J Garcia-Velloso, Katharina Lückerath, et al.
Oncotarget
|
October 27, 2016
Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI
Constantin Lapa, Theresa Reiter, Malte Kircher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 29, 2021
<sup>68</sup>Ga-Pentixafor PET/CT for Detection of Chemokine Receptor CXCR4 Expression in Myeloproliferative Neoplasms
Sabrina Kraus, Alexander Dierks, Leo Rasche, et al.
Cancers
|
April 29, 2020
<sup>18</sup>F-FDG and <sup>11</sup>C-Methionine PET/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET Biomarkers
Maria I Morales-Lozano, Oliver Viering, Samuel Samnick, et al.
Frontiers in Oncology
|
June 28, 2019
[<sup>68</sup>Ga]-Pentixafor PET/CT for CXCR4-Mediated Imaging of Vestibular Schwannomas
Maria Breun, Camelia M Monoranu, Almuth F Kessler, et al.
Molecular Imaging and Biology
|
August 1, 2024
Interobserver Agreement Rates on CXCR4-Directed PET/CT in Patients with Marginal Zone Lymphoma
Rudolf A Werner, Yingjun Zhi, Niklas Dreher, et al.
Page
of 27